go back

ASXL1 Gene Test for Bone Marrow Disorders

Rhode Island rates for HCPCS 81175

A laboratory test that examines the ASXL1 gene in a blood or bone marrow sample for changes associated with disorders of the bone marrow, including myelodysplastic syndromes and certain leukemias. Findings help confirm a diagnosis and give a sense of how the disease is likely to behave. Results are read alongside the blood counts, marrow findings, and other testing.

Rates data updated July 2026.

Facilitymedian $1,047 · 10th–90th $708$3,8900%10%20%10th90th$1,047Professionalmedian $513 · 10th–90th $427$6760%20%10th90th$513$500.0$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,041.74
Median
$3,162.28
Typical High
$3,890.45
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489.78
Median
$489.78
Typical High
$524.81
BCBS
Setting
Facility
Modifier
Global
Typical Low
$630.96
Median
$776.25
Typical High
$870.96
BCBS
Setting
Professional
Modifier
Global
Typical Low
$512.86
Median
$512.86
Typical High
$776.25
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,862.09
Median
$1,862.09
Typical High
$1,862.09
Cigna
Setting
Professional
Modifier
Global
Typical Low
$354.81
Median
$398.11
Typical High
$1,096.48
United
Setting
Facility
Modifier
Global
Typical Low
$812.83
Median
$812.83
Typical High
$1,000.00
United
Setting
Professional
Modifier
Global
Typical Low
$281.84
Median
$426.58
Typical High
$1,023.29